Glenn P. Sblendorio
2015 - Medicines
In 2015, Glenn P. Sblendorio earned a total compensation of $2.5M as Former President and Chief Financial Officer at Medicines, a 5% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $355,675 |
|---|---|
| Option Awards | $1,052,986 |
| Salary | $658,658 |
| Stock Awards | $449,992 |
| Other | $11,304 |
| Total | $2,528,615 |
Sblendorio received $1.1M in option awards, accounting for 42% of the total pay in 2015.
Sblendorio also received $355.7K in non-equity incentive plan, $658.7K in salary, $450K in stock awards and $11.3K in other compensation.
Rankings
In 2015, Glenn P. Sblendorio's compensation ranked 3,786th out of 13,638 executives tracked by ExecPay. In other words, Sblendorio earned more than 72.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,786 out of 13,638 | 72nd |
Division Manufacturing | 1,378 out of 5,190 | 73rd |
Major group Chemicals And Allied Products | 497 out of 1,854 | 73rd |
Industry group Drugs | 398 out of 1,528 | 74th |
Industry Pharmaceutical Preparations | 314 out of 1,182 | 73rd |
Source: SEC filing on April 25, 2016.
Sblendorio's colleagues
We found four more compensation records of executives who worked with Glenn P. Sblendorio at Medicines in 2015.